A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mitapivat Desethylcyclopropane Impurity | CAS 1260081-87-5 - 请求报价

media.product.imagealternatetextformat.details

Mitapivat Desethylcyclopropane Impurity

SZ目录编号:SZ-M133003
CAS 号
1260081-87-5
分子式
C20H20N4O3S
分子量
396.5
投资状态
Under QC Approval
Rel. CAS No1384448-27-4 (HCl salt)

化学名称 :

运输温度 :

HSN编码 :

原产国 :

微笑 :

使用说明:

Mitapivat Desethylcyclopropane Impurity is chemically N-(4-(piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide. Mitapivat Desethylcyclopropane Impurity is supplied with detailed characterization data compliant with regulatory guideline. Mitapivat Desethylcyclopropane Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mitapivat.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

应用与法规使用场景

购买 1260081-87-5

采购 1260081-87-5

订购 1260081-87-5

询问 1260081-87-5

price of 1260081-87-5

1260081-87-5 供应商

1260081-87-5 制造商

1260081-87-5 出口商

buy high quality Mitapivat Desethylcyclopropane Impurity

采购 Mitapivat Desethylcyclopropane Impurity

Mitapivat Desethylcyclopropane Impurity 供应商

Mitapivat Desethylcyclopropane Impurity 制造商

Mitapivat Desethylcyclopropane Impurity 价格

订购 Mitapivat Desethylcyclopropane Impurity

询问 Mitapivat Desethylcyclopropane Impurity

Mitapivat Desethylcyclopropane Impurity 成本

Mitapivat Desethylcyclopropane Impurity 供应商

Mitapivat Desethylcyclopropane Impurity 分销商

Mitapivat Desethylcyclopropane Impurity 用于方法验证

Mitapivat 对照标准

Mitapivat Desethylcyclopropane Impurity 用于ANDA申报

Mitapivat Desethylcyclopropane Impurity 用于强制降解研究

Mitapivat Desethylcyclopropane Impurity 鉴别标准

Mitapivat Desethylcyclopropane Impurity 用于DMF申报

ℹ️

免责声明

SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。

SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。

,